Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT05412056
Eligibility Criteria:
Inclusion Criteria:
* All women age ≥ 18 years old
* Viable twin pregnancy with dichorionic diamnioticity or monochorionic diamnioticity
* Gestational age less than 20 completed weeks
Exclusion Criteria:
* High order multiple pregnancy such as triplets or higher order multiple pregnancy with fetal reduction to twin pregnancy
* Monochorionic monoamniotic twin pregnancy
* Twin pregnancy with silent miscarriage of one twin
* Excessive vaginal bleeding
* Presence of congenital anomaly
* Rupture of membranes
* Congenital uterine anomaly
* Unwillingness or inability to comply with study procedures
* Known paternal or maternal abnormal karyotype
* Known renal, liver, or heart failure
* Pre-existing type 1 or 2 diabetes
* Treatment with metformin at the time of screening
* Allergic to metformin
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT05412056
Study Brief:
Protocol Section:
NCT05412056